Abiopharma

News list

Director Congleton Jon 🟢 acquired 50.7K shares (1 derivative) of IMMUNIC, INC. (IMUX) at $10.90 Transaction Date: Jun 29, 2026 | Filing ID: 000892

Full text

News bot June 29, 2026, 10:19 p.m.
🔍 Congleton Jon (Director)

Company: IMMUNIC, INC. (IMUX)

Report Date: 2026-06-29
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 50,740
Detailed Transactions and Holdings:
- Acquired 50,740 shares of Stock Option at $10.9 per share (Derivative)
  Date: 2026-06-29 | Code: A | Expires: 2036-03-27 | equity_swap_involved: 0 | shares_owned_after: 50,740.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Represents options to purchase shares of common stock conditionally approved by the Board of Directors on March 27, 2026, subject to approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, as amended, by the Company's stockholders, which approval was obtained at the Company's 2026 Annual Meeting of Stockholders held on June 29, 2026.
- F2: The options vest in thirty-six (36) equal installments on each monthly anniversary of March 27, 2026.